| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Note |
Online resource; title from PDF title page (EBSCO, viewed April 13, 2017). |
| Bibliography |
Includes bibliographical references and index. |
| Summary |
Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed. Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer's, cancer, and malaria. With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders. |
| Subject |
Drugs -- Design.
|
|
Drug Design |
|
Médicaments -- Conception.
|
|
MEDICAL -- Pharmacology.
|
|
Drugs -- Design
|
| Added Author |
Decker, M. (Michael), editor.
|
| Other Form: |
Print version: Design of hybrid molecules for drug development. Oxford : Elsevier, 2017 0081010117 9780081010112 (OCoLC)960278882 |
| ISBN |
9780081011188 (electronic bk.) |
|
0081011180 (electronic bk.) |
|
9780081010112 |
|
0081010117 |
| Standard No. |
AU@ 000059828217 |
|
AU@ 000066135987 |
|
CHBIS 011069417 |
|
CHVBK 499784014 |
|
AU@ 000068464304 |
|
